ICU Medical Pre-Tax Profit Margin 2012-2025 | ICUI
ICU Medical pre-tax profit margin from 2012 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| ICU Medical Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-09-30 | $2.32B | $0.03B | 1.21% |
| 2025-06-30 | $2.37B | $0.01B | 0.55% |
| 2025-03-31 | $2.42B | $-0.04B | -1.69% |
| 2024-12-31 | $2.38B | $-0.07B | -2.81% |
| 2024-09-30 | $2.34B | $-0.11B | -4.79% |
| 2024-06-30 | $2.30B | $-0.10B | -4.30% |
| 2024-03-31 | $2.26B | $-0.10B | -4.52% |
| 2023-12-31 | $2.26B | $-0.08B | -3.45% |
| 2023-09-30 | $2.25B | $-0.06B | -2.76% |
| 2023-06-30 | $2.29B | $-0.08B | -3.40% |
| 2023-03-31 | $2.31B | $-0.07B | -3.12% |
| 2022-12-31 | $2.28B | $-0.11B | -5.00% |
| 2022-09-30 | $2.04B | $-0.07B | -3.43% |
| 2022-06-30 | $1.78B | $-0.01B | -0.62% |
| 2022-03-31 | $1.54B | $0.04B | 2.66% |
| 2021-12-31 | $1.32B | $0.12B | 9.34% |
| 2021-09-30 | $1.30B | $0.13B | 10.03% |
| 2021-06-30 | $1.28B | $0.12B | 9.23% |
| 2021-03-31 | $1.26B | $0.10B | 8.25% |
| 2020-12-31 | $1.27B | $0.10B | 7.63% |
| 2020-09-30 | $1.27B | $0.09B | 6.95% |
| 2020-06-30 | $1.26B | $0.10B | 7.57% |
| 2020-03-31 | $1.26B | $0.10B | 8.07% |
| 2019-12-31 | $1.27B | $0.12B | 9.08% |
| 2019-09-30 | $1.29B | $0.08B | 6.36% |
| 2019-06-30 | $1.31B | $0.05B | 3.82% |
| 2019-03-31 | $1.36B | $0.05B | 3.83% |
| 2018-12-31 | $1.40B | $0.02B | 1.64% |
| 2018-09-30 | $1.43B | $0.08B | 5.25% |
| 2018-06-30 | $1.45B | $0.08B | 5.47% |
| 2018-03-31 | $1.42B | $0.01B | 0.71% |
| 2017-12-31 | $1.29B | $0.05B | 4.02% |
| 2017-09-30 | $1.02B | $0.03B | 2.55% |
| 2017-06-30 | $0.77B | $0.04B | 5.69% |
| 2017-03-31 | $0.54B | $0.11B | 19.89% |
| 2016-12-31 | $0.38B | $0.09B | 22.37% |
| 2016-09-30 | $0.37B | $0.08B | 22.46% |
| 2016-06-30 | $0.36B | $0.09B | 23.69% |
| 2016-03-31 | $0.35B | $0.08B | 23.71% |
| 2015-12-31 | $0.34B | $0.07B | 20.53% |
| 2015-09-30 | $0.33B | $0.07B | 20.85% |
| 2015-06-30 | $0.32B | $0.05B | 16.46% |
| 2015-03-31 | $0.32B | $0.04B | 12.93% |
| 2014-12-31 | $0.31B | $0.04B | 12.94% |
| 2014-09-30 | $0.31B | $0.04B | 13.68% |
| 2014-06-30 | $0.31B | $0.05B | 15.65% |
| 2014-03-31 | $0.31B | $0.05B | 16.29% |
| 2013-12-31 | $0.31B | $0.05B | 16.88% |
| 2013-09-30 | $0.32B | $0.06B | 18.18% |
| 2013-06-30 | $0.32B | $0.06B | 18.93% |
| 2013-03-31 | $0.32B | $0.06B | 20.00% |
| 2012-12-31 | $0.32B | $0.06B | 19.87% |
| 2012-09-30 | $0.31B | $0.07B | 22.58% |
| 2012-06-30 | $0.31B | $0.07B | 21.31% |
| 2012-03-31 | $0.31B | $0.07B | 21.24% |
| 2011-12-31 | $0.30B | $0.07B | 21.93% |
| 2011-09-30 | $0.30B | $0.06B | 18.39% |
| 2011-06-30 | $0.30B | $0.06B | 18.73% |
| 2011-03-31 | $0.29B | $0.05B | 18.62% |
| 2010-12-31 | $0.28B | $0.05B | 16.96% |
| 2010-09-30 | $0.28B | $0.04B | 15.22% |
| 2010-06-30 | $0.25B | $0.04B | 14.17% |
| 2010-03-31 | $0.24B | $0.03B | 13.87% |
| 2009-12-31 | $0.23B | $0.04B | 16.23% |
| 2009-09-30 | $0.22B | $0.04B | 19.27% |
| 2009-06-30 | $0.22B | $0.05B | 21.00% |
| 2009-03-31 | $0.22B | $0.04B | 20.47% |
| 2008-12-31 | $0.21B | $0.04B | 17.96% |
| 2008-09-30 | $0.20B | $0.03B | 15.90% |
| 2008-06-30 | $0.19B | $0.03B | 14.05% |
| 2008-03-31 | $0.19B | $0.02B | 12.43% |
| 2007-12-31 | $0.19B | $0.03B | 17.99% |
| 2007-09-30 | $0.20B | $0.03B | 16.33% |
| 2007-06-30 | $0.20B | $0.04B | 17.50% |
| 2007-03-31 | $0.20B | $0.04B | 20.30% |
| 2006-12-31 | $0.20B | $0.04B | 17.82% |
| 2006-09-30 | $0.19B | $0.04B | 19.79% |
| 2006-06-30 | $0.19B | $0.04B | 19.47% |
| 2006-03-31 | $0.18B | $0.03B | 18.89% |
| 2005-12-31 | $0.16B | $0.03B | 19.62% |
| 2005-09-30 | $0.13B | $0.02B | 15.38% |
| 2005-06-30 | $0.10B | $0.01B | 9.09% |
| 2005-03-31 | $0.08B | $0.01B | 8.75% |
| 2004-12-31 | $0.08B | $0.01B | 9.33% |
| 2004-09-30 | $0.09B | $0.02B | 23.33% |
| 2004-06-30 | $0.10B | $0.03B | 30.00% |
| 2004-03-31 | $0.10B | $0.03B | 31.31% |
| 2003-12-31 | $0.11B | $0.04B | 32.41% |
| 2003-09-30 | $0.10B | $0.03B | 33.33% |
| 2003-06-30 | $0.10B | $0.03B | 35.42% |
| 2003-03-31 | $0.10B | $0.04B | 36.73% |
| 2002-12-31 | $0.09B | $0.03B | 36.36% |
| 2002-09-30 | $0.09B | $0.03B | 34.12% |
| 2002-06-30 | $0.08B | $0.03B | 33.33% |
| 2002-03-31 | $0.08B | $0.03B | 33.33% |
| 2001-12-31 | $0.07B | $0.02B | 34.78% |
| 2001-09-30 | $0.07B | $0.02B | 35.38% |
| 2001-06-30 | $0.06B | $0.02B | 34.43% |
| 2001-03-31 | $0.06B | $0.02B | 34.48% |
| 2000-12-31 | $0.06B | $0.02B | 33.33% |
| 2000-09-30 | $0.05B | $0.02B | 33.96% |
| 2000-06-30 | $0.05B | $0.02B | 34.62% |
| 2000-03-31 | $0.05B | $0.02B | 34.00% |
| 1999-12-31 | $0.05B | $0.02B | 31.91% |
| 1999-09-30 | $0.04B | $0.01B | 29.55% |
| 1999-06-30 | $0.04B | $0.01B | 30.23% |
| 1999-03-31 | $0.04B | $0.01B | 29.27% |
| 1998-12-31 | $0.04B | $0.01B | 30.00% |
| 1998-09-30 | $0.04B | $0.02B | 46.15% |
| 1998-06-30 | $0.04B | $0.02B | 40.54% |
| 1998-03-31 | $0.03B | $0.01B | 41.18% |
| 1997-12-31 | $0.03B | $0.01B | 41.94% |
| 1997-09-30 | $0.03B | $0.01B | 35.71% |
| 1997-06-30 | $0.03B | $0.01B | 46.15% |
| 1997-03-31 | $0.03B | $0.01B | 48.00% |
| 1996-12-31 | $0.02B | $0.02B | 66.67% |
| 1996-09-30 | $0.02B | $0.01B | 52.17% |
| 1996-06-30 | $0.02B | $0.01B | 50.00% |
| 1996-03-31 | $0.02B | $0.01B | 45.45% |
| 1995-12-31 | $0.02B | $0.01B | 23.81% |
| 1995-09-30 | $0.02B | $0.00B | 19.05% |
| 1995-06-30 | $0.02B | $0.00B | 15.79% |
| 1995-03-31 | $0.02B | $0.00B | 17.65% |
| 1994-12-31 | $0.02B | $0.00B | 25.00% |
| 1994-09-30 | $0.02B | $0.00B | 26.67% |
| 1994-06-30 | $0.01B | $0.01B | 35.71% |
| 1994-03-31 | $0.01B | $0.01B | 41.67% |
| 1993-12-31 | $0.01B | $0.00B | 36.36% |
| 1993-09-30 | $0.01B | $0.00B | 40.00% |
| 1993-06-30 | $0.01B | $0.00B | 36.36% |
| 1993-03-31 | $0.01B | $0.00B | 36.36% |
| 1992-12-31 | $0.01B | $0.00B | 40.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.806B | $2.382B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $192.719B | 21.52 |
| EssilorLuxottica (ESLOY) | France | $140.970B | 0.00 |
| Stryker (SYK) | United States | $137.019B | 26.29 |
| Medtronic (MDT) | Ireland | $131.919B | 18.28 |
| Boston Scientific (BSX) | United States | $113.066B | 25.01 |
| Medline (MDLN) | United States | $62.139B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.969B | 0.00 |
| ResMed (RMD) | United States | $39.571B | 26.42 |
| GE HealthCare Technologies (GEHC) | United States | $36.756B | 17.61 |
| Agilent Technologies (A) | United States | $36.736B | 23.22 |
| Koninklijke Philips (PHG) | Netherlands | $28.368B | 18.53 |
| Terumo (TRUMY) | Japan | $19.441B | 21.97 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.819B | 11.11 |
| Insulet (PODD) | United States | $17.019B | 52.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.739B | 0.00 |
| Baxter (BAX) | United States | $11.170B | 9.02 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.133B | 29.24 |
| Demant (WILYY) | Denmark | $6.521B | 0.00 |
| Envista Holdings (NVST) | United States | $4.785B | 24.25 |
| Lantheus Holdings (LNTH) | United States | $4.303B | 13.11 |
| BillionToOne (BLLN) | United States | $4.147B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.189B | 14.81 |
| Haemonetics (HAE) | United States | $2.778B | 12.06 |
| Neogen (NEOG) | United States | $2.349B | 51.43 |
| Phibro Animal Health (PAHC) | United States | $2.151B | 18.95 |
| Perrigo (PRGO) | Ireland | $2.015B | 5.05 |
| LeMaitre Vascular (LMAT) | United States | $1.983B | 39.92 |
| QuidelOrtho (QDEL) | United States | $1.977B | 12.71 |
| AtriCure (ATRC) | United States | $1.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.622B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.486B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.475B | 64.64 |
| AdaptHealth (AHCO) | United States | $1.442B | 20.88 |
| Capricor Therapeutics (CAPR) | United States | $1.130B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.080B | 320.43 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.021B | 0.00 |
| InMode (INMD) | Israel | $0.953B | 10.77 |
| Tilray Brands (TLRY) | Canada | $0.883B | 0.00 |
| Valneva SE (VALN) | France | $0.817B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.803B | 0.00 |
| Omeros (OMER) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.747B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.587B | 15.91 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.427B | 72.60 |
| Cerus (CERS) | United States | $0.423B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.405B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.377B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.328B | 26.18 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.292B | 0.00 |
| Quanterix (QTRX) | United States | $0.284B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.237B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.222B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| High Tide (HITI) | Canada | $0.207B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.197B | 17.71 |
| Aurora Cannabis (ACB) | Canada | $0.197B | 58.00 |
| OraSure Technologies (OSUR) | United States | $0.194B | 0.00 |
| Accendra Health (ACH) | United States | $0.185B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.179B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.144B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.136B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.72 |
| MacroGenics (MGNX) | United States | $0.115B | 0.00 |
| Biote (BTMD) | United States | $0.102B | 4.46 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 24.00 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.77 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.033B | 16.63 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| ZeroStack (ZSTK) | United States | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |